COMMUNIQUÉS West-GlobeNewswire

-
Lexicon to Present Data at the 85th Scientific Sessions of the American Diabetes Association (ADA)
18/06/2025 -
Intelligent Bio Solutions Launches In-House Fingerprint Drug Testing Across 20+ Sites for Major Australian Waste Operator, Accelerating APAC Expansion
18/06/2025 -
Tevogen Updates on Development of EBV-Specific T Cell Therapy with Support from AI-Powered Target Discovery
18/06/2025 -
Sienna Senior Living Completes Second Acquisition in Ottawa in 2025
18/06/2025 -
Eyenovia Announces Appointment of a Strategic Advisor for Digital Asset Treasury Strategy and Amendment of Debt Agreement with Avenue Capital Group
18/06/2025 -
Prenetics Becomes First Healthcare Company to Execute Aggressive Bitcoin Treasury Strategy, Secures $20M in BTC, Appoints Former OKEx COO to Board
18/06/2025 -
Akari Therapeutics Bolsters Global IP Estate for its Novel Antibody Drug Conjugate (ADC) Immuno-Oncology Payload, PH1, with Recent Granting of Patent Protection Across India
18/06/2025 -
INVO Fertility Expands Telehealth Capabilities at Its Wisconsin Fertility Institute
18/06/2025 -
Synfini Inc. and O2nix Bio Announce Strategic Collaboration to Develop Novel Cancer Therapeutics Targeting FTSJ1
18/06/2025 -
Outlook Therapeutics to Participate in a Virtual Investor Lunch Break Event
18/06/2025 -
Orchestra BioMed Showcases AVIM Therapy as Purpose-Built Solution for Hypertensive Heart Disease at CSI Frankfurt 2025
18/06/2025 -
Hairmax Partners with Truemed to Accept FSA/HSA Payments on FDA-Cleared Laser Hair Growth Devices
18/06/2025 -
BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Compelling BRTX-100 Clinical Data, Leadership Enhancements and Strategic updates
18/06/2025 -
Eolo Pharma Publishes First-in-Human Study in Nature Metabolism on Novel Obesity Drug Activating Energy-Burning Pathway
18/06/2025 -
Bioxytran Secures a Source of GMP Quality Camel Hemoglobin
18/06/2025 -
Bay Area Lyme Foundation Announces New Executive Director Josh Wein
18/06/2025 -
Human Appeal announces summertime UK Comedy Tour
18/06/2025 -
Rarecells, Inc. Appoints Dr. Rita Shaknovich to Scientific Advisory Board
18/06/2025 -
Biomea Fusion Reports Preclinical Data for BMF-650, a Next-Generation Oral GLP-1 Receptor Agonist Candidate, Demonstrating Robust Weight Loss and Appetite Suppression in Obese Non-Human Primates
18/06/2025
Pages